WebSynnovis, formerly Viapath, is a London-based provider of pathology services. It is a partnership between Guy's and St Thomas' NHS Foundation Trust, King's College Hospital NHS Foundation Trust, and SYNLAB UK & Ireland. [1] The Synnovis brand was launched in October 2024. [2] WebNov 7, 2024 · We are Synnovis: a scientific organisation with a clinical purpose. ... the partnership will build on Viapath’s existing expertise to deliver and transform NHS pathology services across South East London over the next 15 years. 3rd June 2024. Staying COVID … Since Lord Carter’s review in 2008, there has been significant change in the … Working with our NHS service partners to set the standard for the future of … The Molecular Pathology Department at Kings’ College Hospital is an established …
Synnovis hiring Quality Manager in London, England, United …
http://www.synnovis.co.uk/ WebOct 4, 2024 · Oct 04, 2024. A pathology partnership performing 32 million tests a year has been relaunched as ‘Synnovis’ – officially heralding the start of a new era for clinicians … th-058 marca helvex
St Thomas
WebDr Tracy Ellison is the Managing Director for Synnovis. Tracy has more than 36 years of experience in pathology and laboratory medicine across the NHS and the commercial sectors. She joined SYNLAB as the transformation director for South East London in 2024 before being promoted to Chief Operating Officer for Synnovis in April 2024. Synnovis was established under the name of GSTS Pathology in 2009 as a partnership with Serco. It was founded in response to the recommendations in the “Report of the Review of NHS Pathology Services in England” chaired by Lord Carter of Coles, published in 2006. GSTS Pathology posted a £5.9 million loss in 2011 but a £3.8m net profit for the year ending December 2013, up from £300,000 in 2012. Income increased by 6% from £87.6m in 2012 to £92.5m in 2013. In 201… WebSynnovis 7,192 followers 8h Report this post Report Report. Back ... th-05u